Snowdome-supported researchers at Peter MacCallum Cancer Centre have discovered how a form of leukaemia fights back against a ground-breaking treatment, providing vital new leads on… Read More
As today is International Clinical Trials Day (commemorating 20 May 1747, the day on which James Lind started his famous trial comparing treatments for scurvy), Snowdome… Read More
Over the last 9 months, Snowdome’s funding efforts have been concentrated on directing just over $1,000,000 into epigenetic treatments for Australians with blood cancers. Snowdome… Read More
Throughout 2013/14, Snowdome was successful in joining several like-minded major donors* to establish the Centre of Research Excellence in Myeloma (CRE-M) in Melbourne. This $3million… Read More
We are proud to share that 215 Australian blood cancer patients have gained access to new, cutting-edge therapies since Snowdome formed in 2010. This year… Read More
In a final analysis of the Peter Mac sponsored Azacitidine/Eltrombopag study, haematologist and research fellow, Dr Michael Dickinson, targets myelodysplastic syndromes and gives us a… Read More
In June this year at the European Haematology Association meeting in Italy, Dr Melita Kenealy, project manager of the Victorian Epigenetics Group, presented the first… Read More